Novartis inspection puts into question who knew what—and when—about Zolgensma data manipulation 

13th August 2019 Uncategorised 0

Novartis, publicly shamed last week for manipulating data in its FDA application for gene therapy Zolgensma, has said that it launched an investigation in March, as soon as it learned of the problem. But records from the lab where the irregularities arose suggest the company’s investigation may not have been as deep or wide as the Swiss drugmaker has proclaimed.

More: Novartis inspection puts into question who knew what—and when—about Zolgensma data manipulation 
Source: fierce